Saturday November 28, 2020

Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s

The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.Two studies presented Monday (July 27) at this year’s virtual Alzheimer’s Association International Conference have demonstrated that flu and pneumococcal vaccines are linked with a lower risk of Alzheimer’s disease. Amanda Heidt | Jul […]

Alzheimer | flu | vaccine |

Saturday November 28, 2020

Decreased influenza activity during the COVID‐19 pandemic—United States, Australia, Chile, and South Africa

Transplant recipients are among the groups for whom the updated recommendations for 2020–2021 influenza vaccination should generally be considered essential, notably in the face of the COVID‐19 pandemic. After recognition of widespread community transmission of SARS‐CoV‐2, the virus that causes coronavirus disease 2019 (COVID‐19), by mid‐ to late‐February 2020, indicators of influenza activity began to […]

influenza |

Saturday November 28, 2020

Favipiravir, an anti-influenza drug against life-threatening RNA virus infections

Favipiravir has been developed as an anti-influenza drug and licensed as an anti-influenza drug in Japan. Additionally, favipiravir is being stockpiled for 2 million people as a countermeasure for novel influenza strains. This drug functions as a chain terminator at the site of incorporation of the viral RNA and reduces the viral load. Favipiravir cures […]

Favipiravir |
Load more